Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC646903 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSPG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FABP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724312 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDGFRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTNAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFG3L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on